Detalhe da pesquisa
1.
BRN2 suppresses apoptosis, reprograms DNA damage repair, and is associated with a high somatic mutation burden in melanoma.
Genes Dev
; 33(5-6): 310-332, 2019 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30804224
2.
Circulating galectin-1 delineates response to bevacizumab in melanoma patients and reprograms endothelial cell biology.
Proc Natl Acad Sci U S A
; 120(3): e2214350120, 2023 01 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36634146
3.
Binimetinib in combination with nivolumab or nivolumab and ipilimumab in patients with previously treated microsatellite-stable metastatic colorectal cancer with RAS mutations in an open-label phase 1b/2 study.
BMC Cancer
; 24(1): 446, 2024 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38600471
4.
Multi-cancer early detection test in symptomatic patients referred for cancer investigation in England and Wales (SYMPLIFY): a large-scale, observational cohort study.
Lancet Oncol
; 24(7): 733-743, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37352875
5.
Interferon-Gamma-Producing CD8+ Tissue Resident Memory T Cells Are a Targetable Hallmark of Immune Checkpoint Inhibitor-Colitis.
Gastroenterology
; 161(4): 1229-1244.e9, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34147519
6.
Lag3: From Bench to Bedside.
Cancer Treat Res
; 183: 185-199, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35551660
7.
Phase 1 study of the ATR inhibitor berzosertib (formerly M6620, VX-970) combined with gemcitabine ± cisplatin in patients with advanced solid tumours.
Br J Cancer
; 125(4): 510-519, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34040175
8.
Checkpoint-blocker-induced autoimmunity is associated with favourable outcome in metastatic melanoma and distinct T-cell expression profiles.
Br J Cancer
; 124(10): 1661-1669, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33723392
9.
Comparative efficacy and safety of adjuvant nivolumab versus other treatments in adults with resected melanoma: a systematic literature review and network meta-analysis.
BMC Cancer
; 21(1): 3, 2021 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33402121
10.
A Phase 2a cohort expansion study to assess the safety, tolerability, and preliminary efficacy of CXD101 in patients with advanced solid-organ cancer expressing HR23B or lymphoma.
BMC Cancer
; 21(1): 851, 2021 Jul 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34301221
11.
Long-term real-world experience with ipilimumab and non-ipilimumab therapies in advanced melanoma: the IMAGE study.
BMC Cancer
; 21(1): 642, 2021 May 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-34051732
12.
Adjuvant nivolumab versus ipilimumab in resected stage IIIB-C and stage IV melanoma (CheckMate 238): 4-year results from a multicentre, double-blind, randomised, controlled, phase 3 trial.
Lancet Oncol
; 21(11): 1465-1477, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32961119
13.
Intratumoural immunotherapies for unresectable and metastatic melanoma: current status and future perspectives.
Br J Cancer
; 123(6): 885-897, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32713938
14.
Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma.
N Engl J Med
; 377(19): 1824-1835, 2017 11 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28891423
15.
Immunophenotypes of pancreatic ductal adenocarcinoma: Meta-analysis of transcriptional subtypes.
Int J Cancer
; 145(4): 1125-1137, 2019 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30720864
16.
A phase 1 study to assess the safety, tolerability, and pharmacokinetics of CXD101 in patients with advanced cancer.
Cancer
; 125(1): 99-108, 2019 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30332497
17.
Focused Ultrasound Hyperthermia for Targeted Drug Release from Thermosensitive Liposomes: Results from a Phase I Trial.
Radiology
; 291(1): 232-238, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30644817
18.
Temporal validation of metabolic nodal response of esophageal cancer to neoadjuvant chemotherapy as an independent predictor of unresectable disease, survival, and recurrence.
Eur Radiol
; 29(12): 6717-6727, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31278574
19.
Routinely staging gastric cancer with 18F-FDG PET-CT detects additional metastases and predicts early recurrence and death after surgery.
Eur Radiol
; 29(5): 2490-2498, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30643947
20.
Correction to: Will the reformed Cancer Drugs Fund address the most common types of uncertainty? An analysis of NICE cancer drug appraisals.
BMC Health Serv Res
; 19(1): 198, 2019 03 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-30922313